Rehman U., Lau ZJ., Philpott C., Lund VJ., Eynon‐Lewis N., Klussmann JP., Manes RP., Judson BL., Kimple AJ., Yarbrough WG., Nayak JV., Hwang PH., Patel ZM., Lechner M.

Key Points Anosmia/hyposmia affected 14.8%–19.6% of participants in the UK and the USA in the post‐pandemic era. Since symptom onset, 37.1%–48.8% of affected participants reported no improvement, while 15.3%–17.6% reported worsening symptoms. Anosmia/hyposmia remains strongly associated with reduced quality of life across both countries. Among respondents reporting anosmia or hyposmia, a high proportion (88.8%–93.5%) also experienced concurrent parosmia.

Persistent Smell and Taste Disorders in the Post‐COVID‐19 Pandemic Era: A Cross‐National Study of Prevalence and Quality of Life in the UK and the USA

Rehman U., Lau ZJ., Philpott C., Lund VJ., Eynon‐Lewis N., Klussmann JP., Manes RP., Judson BL., Kimple AJ., Yarbrough WG., Nayak JV., Hwang PH., Patel ZM., Lechner M.

DOI

Type

Publisher

Publication Date